Search Results 1031-1040 of 18648 for Relapse

  1. Teclistamab-cqyv (subcutaneous route) - Side effects & uses - Mayo Clinic

    Teclistamab-cqyv injection is used to treat relapsed (cancer that has come back) or refractory (cancer that did not respond to treatment) multiple myeloma ...

  2. Publications - Kristen B. McCullough, Pharm.D., R.Ph. - Mayo Clinic

    Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent ...

  3. Oncology (Medical) - Clinical trials

    Additionally, no studies to date have investigated this during intralesional tumor resections. NL-201 in Patients With Relapsed or Refractory Cancer. Rochester, ...

  4. Publications - Javier L. Munoz, M.D., M.B.A. - Mayo Clinic

    ... relapsed/refractory non-Hodgkin lymphoma: A multicenter consensus approach. Am J Hematol. 2024 Jan; 99 (1):124-134 Epub 2023 Nov 11. View PubMed; Gaulin C ...

  5. Ricardo D. Parrondo, M.D. - Doctors and Medical Staff - Mayo Clinic

    Expertise in management of relapsed/refractory plasma cell dyscrasias; Development of early and late-phase clinical trials for plasma cell dyscrasias ...

  6. T Cell Lymphoma Clinical Trials - Mayo Clinic Research

    This phase II trial studies how well giving ruxolitinib phosphate (oral JAK inhibitor INCB18424) works in treating patients with relapsed or refractory ...

  7. Treating pediatric patients with primary and recurrent rhabdomyosarcoma - Mayo Clinic

    ... , Mayo Clinic treats pediatric patients with primary and recurrent rhabdomyosarcoma, offering a cutting-edge treatment option for relapsed disease.

  8. Publications - Patrick B. Johnston, M.D., Ph.D. - Mayo Clinic

    ... Relapsed/Refractory Non-Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk ... Incidence of Central Nervous System Relapse in Primary Mediastinal Large B ...

  9. A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

    ... relapse prevention. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  10. A Study Using Risk Factors To Determine Treatment For Children With Favorable Histology Wilms Tumors (FHWT) - Mayo Clinic

    ... relapse) and not all survive. Previous research has identified features of FHWT that are associated with higher or lower risks of relapse. The term "risk ...